insights_auto
Zašto je 0QF skočio 5,17%?
Istražite detaljnijechevron_right
0QF:ETR
Moderna Inc
176,84 €
arrow_upward
+5,17%(+8,70) 1D
5. lis, 17:35:42 GMT+2 · EUR
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za 0QF...
Otvori
169,74 €
Najviša
176,84 €
Najniža
166,12 €
Trž. kap.
81,13 mlr.
Prosj. kol.
31,26 tis.
Količina
31,12 tis.
52-tjed. najviša
184,20 €
52-tjed. najniža
19,37 €
Broj djelatnika
5 tis.
Otvori
169,74 €
Najviša
176,84 €
Najniža
166,12 €
Trž. kap.
81,13 mlr.
Prosj. kol.
31,26 tis.
Količina
31,12 tis.
52-tjed. najviša
184,20 €
52-tjed. najniža
19,37 €
Broj djelatnika
5 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
The Daily Free Press
·
prije 1 sat
The ‘Edison of Medicine’: Moderna founder visits BU for Q&A event, shares encouragement, life experience
Yahoo Finance
·
prije 5 sati
NVAX Stock Outruns Moderna As Vaxcyte’s Shot Clears A Late-Stage Test
Stock Titan
·
prije 6 sati
Moderna (MRNA) COO Juan Andres reports direct ownership of 125,000 common shares.
AD HOC NEWS
·
prije 9 sati
Moderna stock gains as COO appointment meets Nasdaq-100 entry
Profil
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
Moderna Inc – informacije
Glavni izvršni direktorStéphane Bancel
Zaposlenici4,7 tis.
Osnovanoruj 2010
Sjedište-
Sektor-
Web-lokacijamodernatx.com